MRK Butterfly Strategy
MRK (Merck & Co., Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV.
MRK (Merck & Co., Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $280.20B, a trailing P/E of 31.39, a beta of 0.20 versus the broader market, a 52-week range of 73.31-125.14, average daily share volume of 9.7M, a public-listing history dating back to 1978, approximately 73K full-time employees. These structural characteristics shape how MRK stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.20 indicates MRK has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. MRK pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a butterfly on MRK?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current MRK snapshot
As of May 15, 2026, spot at $111.64, ATM IV 29.27%, IV rank 46.00%, expected move 8.39%. The butterfly on MRK below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this butterfly structure on MRK specifically: MRK IV at 29.27% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 8.39% (roughly $9.37 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MRK expiries trade a higher absolute premium for lower per-day decay. Position sizing on MRK should anchor to the underlying notional of $111.64 per share and to the trader's directional view on MRK stock.
MRK butterfly setup
The MRK butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MRK near $111.64, the first option leg uses a $106.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MRK chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MRK shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $106.00 | $7.00 |
| Sell 2 | Call | $112.00 | $3.55 |
| Buy 1 | Call | $117.00 | $1.55 |
MRK butterfly risk and reward
- Net Premium / Debit
- -$145.00
- Max Profit (per contract)
- $434.40
- Max Loss (per contract)
- -$145.00
- Breakeven(s)
- $107.45, $116.55
- Risk / Reward Ratio
- 2.996
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
MRK butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on MRK. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$145.00 |
| $24.69 | -77.9% | -$145.00 |
| $49.38 | -55.8% | -$145.00 |
| $74.06 | -33.7% | -$145.00 |
| $98.74 | -11.6% | -$145.00 |
| $123.43 | +10.6% | -$45.00 |
| $148.11 | +32.7% | -$45.00 |
| $172.79 | +54.8% | -$45.00 |
| $197.47 | +76.9% | -$45.00 |
| $222.16 | +99.0% | -$45.00 |
When traders use butterfly on MRK
Butterflies on MRK are pinning bets - traders use them when they expect MRK to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
MRK thesis for this butterfly
The market-implied 1-standard-deviation range for MRK extends from approximately $102.27 on the downside to $121.01 on the upside. A MRK long call butterfly is a pinning play: it pays maximum at the middle strike if MRK settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current MRK IV rank near 46.00% is mid-range against its 1-year distribution, so the IV signal is neutral; the butterfly thesis on MRK should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MRK options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MRK-specific events.
MRK butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MRK positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MRK alongside the broader basket even when MRK-specific fundamentals are unchanged. Always rebuild the position from current MRK chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on MRK?
- A butterfly on MRK is the butterfly strategy applied to MRK (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With MRK stock trading near $111.64, the strikes shown on this page are snapped to the nearest listed MRK chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MRK butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the MRK butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 29.27%), the computed maximum profit is $434.40 per contract and the computed maximum loss is -$145.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MRK butterfly?
- The breakeven for the MRK butterfly priced on this page is roughly $107.45 and $116.55 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MRK market-implied 1-standard-deviation expected move is approximately 8.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on MRK?
- Butterflies on MRK are pinning bets - traders use them when they expect MRK to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current MRK implied volatility affect this butterfly?
- MRK ATM IV is at 29.27% with IV rank near 46.00%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.